Robert H Collins

9PUBLICATIONS
88CO-AUTHORS
Nanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Child language acquisitionHaematological tumoursMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 09, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants.

Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari

|Feb 07, 2024
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML.

Eunice S Wang, Aaron D Goldberg, Martin Tallman

|Dec 12, 2023
CML and the WHO: Why?

Ellin Berman, Neil P Shah, Michael Deninger

|Aug 17, 2023
Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.

Mohammad Faizan Zahid, Kelsey Moriarty, Courtney Dryden

|Oct 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.

Junhua Lyu, Yuxuan Liu, Lihu Gong

|Mar 27, 2021
Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant.

Courtney D DiNardo, Eytan M Stein, Arnaud Pigneux

Pageof 2

Frequent Collaborators

3 joint publications

Brian J Druker

3 joint publications

Stephen S Chung

3 joint publications

Yazan F Madanat

2 joint publications

Prapti Patel